Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00034125

Femme Homme

Extrait

To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.


Critère d'inclusion

  • Breast Neoplasms


Liens